These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33156984)

  • 1. Black Carbon Content in Airway Macrophages is Associated with Reduced CD80 Expression and Increased Exacerbations in Former Smokers With COPD.
    Tejwani V; Moughames E; Suresh K; Tang SE; Mair LG; Romero K; Putcha N; Alexis NE; Woo H; D'Alessio FR; Hansel NN
    Chronic Obstr Pulm Dis; 2021 Jan; 8(1):91-9. PubMed ID: 33156984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS.
    Tejwani V; Woo H; Liu C; Tillery AK; Gassett AJ; Kanner RE; Hoffman EA; Martinez FJ; Woodruff PG; Barr RG; Fawzy A; Koehler K; Curtis JL; Freeman CM; Cooper CB; Comellas AP; Pirozzi C; Paine R; Tashkin D; Krishnan JA; Sack C; Putcha N; Paulin LM; Zusman M; Kaufman JD; Alexis NE; Hansel NN
    Respir Res; 2022 Nov; 23(1):310. PubMed ID: 36376879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoor particulate matter exposure is associated with increased black carbon content in airway macrophages of former smokers with COPD.
    Belli AJ; Bose S; Aggarwal N; DaSilva C; Thapa S; Grammer L; Paulin LM; Hansel NN
    Environ Res; 2016 Oct; 150():398-402. PubMed ID: 27372063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway and Systemic Prostaglandin E2 Association with COPD Symptoms and Macrophage Phenotype.
    Tejwani V; Villabona-Rueda AF; Khare P; Zhang C; Le A; Putcha N; D'Alessio F; Alexis NE; Hansel NN; Fawzy A
    Chronic Obstr Pulm Dis; 2023 Apr; 10(2):159-169. PubMed ID: 36976551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
    Löfdahl JM; Wahlström J; Sköld CM
    Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease.
    Ho T; Nichols M; Nair G; Radford K; Kjarsgaard M; Huang C; Bhalla A; Lavigne N; Mukherjee M; Surette M; Macri J; Nair P
    Respir Res; 2022 Jan; 23(1):8. PubMed ID: 35022042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating carbon content in airway macrophages as a biomarker of personal exposure to fine particulate matter and its acute respiratory effects.
    Yin G; Wu X; Wu Y; Li H; Gao L; Zhu X; Jiang Y; Wang W; Shen Y; He Y; Chen C; Niu Y; Zhang Y; Mao R; Zeng Y; Kan H; Chen Z; Chen R
    Chemosphere; 2021 Nov; 283():131179. PubMed ID: 34146873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
    Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
    Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heterogeneity of airway macrophage in different clinical phenotypes of COPD patients with frequent or infrequent exacerbations].
    Chen X; Tang Y; Wang W; Zhu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 44(12):1376-1384. PubMed ID: 31969502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD.
    Ween MP; White JB; Tran HB; Mukaro V; Jones C; Macowan M; Hodge G; Trim PJ; Snel MF; Hodge SJ
    Sci Rep; 2021 Feb; 11(1):4106. PubMed ID: 33602992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
    Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
    JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort.
    Maselli DJ; Yen A; Wang W; Okajima Y; Dolliver WR; Mercugliano C; Anzueto A; Restrepo MI; Aksamit TR; Basavaraj A; Aliberti S; Young KA; Kinney GL; Wells JM; San José Estépar R; Lynch DA; Diaz AA
    Radiology; 2021 Sep; 300(3):706-714. PubMed ID: 34156303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD.
    Pons AR; Noguera A; Blanquer D; Sauleda J; Pons J; Agustí AG
    Eur Respir J; 2005 Apr; 25(4):647-52. PubMed ID: 15802338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic Airway Inflammation in Patients with Stable Biomass Smoke- versus Tobacco Smoke-Associated Chronic Obstructive Pulmonary Disease.
    Fernandes L; Rane S; Mandrekar S; Mesquita AM
    J Health Pollut; 2019 Dec; 9(24):191209. PubMed ID: 31893170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study.
    Mohan S; Ho T; Kjarsgaard M; Radford K; Borhan AS; Thabane L; Nair P
    BMC Pulm Med; 2017 Apr; 17(1):60. PubMed ID: 28403845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon load in airway macrophages as a biomarker of exposure to particulate air pollution; a longitudinal study of an international Panel.
    Bai Y; Bové H; Nawrot TS; Nemery B
    Part Fibre Toxicol; 2018 Mar; 15(1):14. PubMed ID: 29540230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.